For citation:
Khachatryan G.R., Fedyaev D.V., Avxentyeva M.V., Dombrovskiy V.S. COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2016;9(1):3-14. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.1.003-014

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.